Rapport Therapeutics Inc RAPP Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain MWA Q1 2026 Earnings EPS Beats Estimates by 647 BioLineRx Ltd BLRX Q3 2024 Earnings Loss Per Share of 007 on No Revenue Shares Surge 9 OSS Q1 2026 Earnings Earnings Beat Driven by Cost Discipline and Strong Demand in AIHPC NAGE Q1 2026 Earnings EPS Beats Estimates by a Slim Margin Stock Declines EXLS Q1 2026 Earnings EPS Beats Estimates by 62 Stock Edges Lower